Non-specific binding can lead to false positives and reduced sensitivity in nanoscale diagnostic tools and biosensors. It can also affect the delivery efficiency of nanoparticles in targeted drug delivery systems. For instance, if nanoparticles adhere non-specifically to unintended tissues or cells, it can result in off-target effects and reduced therapeutic efficacy.
